1333 related articles for article (PubMed ID: 11960540)
1. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus.
Shalauta MD; Saad R
Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
[TBL] [Abstract][Full Text] [Related]
4. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of gastroesophageal reflux and Barrett esophagus].
von Schrenck T
Zentralbl Chir; 2000; 125(5):414-23. PubMed ID: 10929625
[TBL] [Abstract][Full Text] [Related]
6. Barrett esophagus and risk of esophageal cancer: a clinical review.
Spechler SJ
JAMA; 2013 Aug; 310(6):627-36. PubMed ID: 23942681
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
8. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
9. Endoscopy for Barrett's esophagus and esophageal adenocarcinoma.
Shaheen N
Am Fam Physician; 2004 May; 69(9):2060-1. PubMed ID: 15152951
[No Abstract] [Full Text] [Related]
10. Barrett Esophagus: A Review.
Sharma P
JAMA; 2022 Aug; 328(7):663-671. PubMed ID: 35972481
[TBL] [Abstract][Full Text] [Related]
11. Management of Barrett's esophagus: cases and questions.
Bresalier R
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
[TBL] [Abstract][Full Text] [Related]
12. Screening for esophageal adenocarcinoma: an evidence-based approach.
Gerson LB; Triadafilopoulos G
Am J Med; 2002 Oct; 113(6):499-505. PubMed ID: 12427500
[TBL] [Abstract][Full Text] [Related]
13. Barrett's Esophagus - State of the Art.
Tanţău M; Laszlo M; Tanţău A
Chirurgia (Bucur); 2018; 113(1):46-60. PubMed ID: 29509531
[TBL] [Abstract][Full Text] [Related]
14. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
Chang JT; Katzka DA
Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
[TBL] [Abstract][Full Text] [Related]
16. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
18. The treatment of Barrett's esophagus.
Hoara P; Gindea C; Birla R; Mocanu A; Tavlas E; Constantinoiu S
J Med Life; 2009; 2(3):241-8. PubMed ID: 20112466
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
Spechler SJ
Med Clin North Am; 2002 Nov; 86(6):1423-45, vii. PubMed ID: 12510459
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
